Daihan Pharmaceutical Co.Ltd (023910) — Strategic Asset Allocation Index
Daihan Pharmaceutical Co.Ltd (023910) has a Strategic Asset Allocation Index of 49.1% as of March 2025. Strategic assets (PP&E of ₩136.58 Billion plus long-term investments of ₩-) total ₩136.58 Billion, measured against net assets of ₩278.35 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 023910 equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Daihan Pharmaceutical Co.Ltd Strategic Asset Allocation Index (2014–2024)
This chart shows how Daihan Pharmaceutical Co.Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2014 to 2024. As of March 2025, the index stands at 49.1%, representing strategic assets of ₩136.58 Billion against net assets of ₩278.35 Billion KRW. For live market cap and overall valuation, see Daihan Pharmaceutical Co.Ltd market capitalisation.
Annual Strategic Asset Allocation Index for Daihan Pharmaceutical Co.Ltd (2014–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Daihan Pharmaceutical Co.Ltd from 2014 to 2024, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 023910 total equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 48.7% | ₩134.44 Billion | ₩134.44 Billion | ₩- | ₩275.99 Billion | ▼ -2.0 pp |
| 2023 | 50.8% | ₩125.85 Billion | ₩125.85 Billion | ₩- | ₩247.97 Billion | ▲ +0.5 pp |
| 2022 | 50.2% | ₩113.24 Billion | ₩113.24 Billion | ₩- | ₩225.40 Billion | ▼ -5.9 pp |
| 2021 | 56.1% | ₩113.83 Billion | ₩113.83 Billion | ₩- | ₩202.81 Billion | ▼ -6.2 pp |
| 2020 | 62.3% | ₩113.40 Billion | ₩113.40 Billion | ₩- | ₩181.92 Billion | ▼ -18.2 pp |
| 2019 | 80.5% | ₩134.26 Billion | ₩125.82 Billion | ₩8.44 Billion | ₩166.78 Billion | ▼ -10.7 pp |
| 2018 | 91.2% | ₩128.05 Billion | ₩120.24 Billion | ₩7.81 Billion | ₩140.36 Billion | ▲ +5.3 pp |
| 2017 | 85.9% | ₩99.54 Billion | ₩93.79 Billion | ₩5.74 Billion | ₩115.88 Billion | ▼ -6.4 pp |
| 2016 | 92.3% | ₩85.76 Billion | ₩80.33 Billion | ₩5.43 Billion | ₩92.94 Billion | ▲ +3.8 pp |
| 2015 | 88.4% | ₩67.96 Billion | ₩64.09 Billion | ₩3.87 Billion | ₩76.84 Billion | ▼ -17.9 pp |
| 2014 | 106.3% | ₩68.16 Billion | ₩64.61 Billion | ₩3.55 Billion | ₩64.10 Billion | — |